Download Free Sample Report

The global Alzheimer Disease Genetic Testing market was valued at US$ 115.2 million in 2023 and is projected to reach US$ 358.7 million by 2030, at a CAGR of 17.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Early-Onset Alzheimer Disease Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Alzheimer Disease Genetic Testing include Mega Genomics, Blueprint Genetics, Generi-Biotech, RxHomeTest, Kashi Labs, 23andMe, LabCorp, Empower DX and SolGent, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Alzheimer's disease is a neurodegenerative disorder that affects memory, cognitive functions, and behavior. While there is no cure for Alzheimer's disease, early detection and treatment can help slow the progression of the disease. Genetic testing can be a useful tool in identifying individuals who may be at higher risk of developing Alzheimer's disease.
This report aims to provide a comprehensive presentation of the global market for Alzheimer Disease Genetic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alzheimer Disease Genetic Testing. This report contains market size and forecasts of Alzheimer Disease Genetic Testing in global, including the following market information:

• Global Alzheimer Disease Genetic Testing Market Revenue, 2019-2024, 2025-2030, ($ millions)
• Global top five companies in 2023 (%)

We surveyed the Alzheimer Disease Genetic Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Alzheimer Disease Genetic Testing Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Alzheimer Disease Genetic Testing Market Segment Percentages, by Type, 2023 (%)

• Early-Onset Alzheimer Disease
• Late-Onset Alzheimer Disease

Global Alzheimer Disease Genetic Testing Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Alzheimer Disease Genetic Testing Market Segment Percentages, by Application, 2023 (%)

• Online
• Offline

Global Alzheimer Disease Genetic Testing Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Alzheimer Disease Genetic Testing Market Segment Percentages, By Region and Country, 2023 (%)

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
• Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
• The Middle East and Africa (Middle East, Africa)
• South and Central America (Brazil, Argentina, Rest of SCA)

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Alzheimer Disease Genetic Testing revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Alzheimer Disease Genetic Testing revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:

• Mega Genomics
• Blueprint Genetics
• Generi-Biotech
• RxHomeTest
• Kashi Labs
• 23andMe
• LabCorp
• Empower DX
• SolGent
• CapitalBio
• Genex Diagnostics
• Sansure

Outline of Major Chapters:

• Chapter 1: Introduces the definition of Alzheimer Disease Genetic Testing, market overview.
• Chapter 2: Global Alzheimer Disease Genetic Testing market size in revenue.
• Chapter 3: Detailed analysis of Alzheimer Disease Genetic Testing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
• Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
• Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
• Chapter 6: Sales of Alzheimer Disease Genetic Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
• Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
• Chapter 8: The main points and conclusions of the report.